MedPath

AMLODIPINO/VALSARTAN MAXMIND 10 MG/160 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

AMLODIPINO/VALSARTAN MAXMIND 10 MG/160 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Pending
Register Number

85844

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Mar 15, 2021

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number85844
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (2)

AMLODIPINO BESILATOActive
Quantity: 13,87 mg
Name: AMLODIPINO BESILATO
VALSARTANActive
Quantity: 160 mg
Name: VALSARTAN

ATC CLASSIFICATION (3)

C09D
C09DB
C09DB01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.